Literature DB >> 9556661

Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.

Y Ben-Yoseph1, J E Reid, B Shapiro, H L Nadler.   

Abstract

4-Methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy derivatives of beta-D glucopyranoside and beta-D-galactopyranoside were prepared by direct sulfation of the commonly used unsulfated derivatives. Both sulfated substrates were highly specific for hexosaminidase A, and in fractionated serum, cells, and tissue preparations, less than 2.5% of these activities were associated with hexosaminidase B and the intermediate isozyme fractions. Serum and leukocytes from patients with infantile Tay-Sachs disease, including a patient with thermolabile hexosaminidase B, had less than 2% of noncarrier activities. Carrier values were clearly separated from those of noncarriers, and no problems were encountered in utilizing sera from pregnant women. The % hexosaminidase A values as derived from the ratio between the activities toward the sulfated and unsulfated substrates in the same specimen were comparable to those obtained by the heat-inactivation method (except for subjects with thermolabile hexosaminidase B) and may be helpful in genotype determination in borderline cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 9556661      PMCID: PMC1684631     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Fractionation of the products of the direct sulphation of monosaccharides on anion-exchange resin.

Authors:  A G LLOYD
Journal:  Biochem J       Date:  1962-06       Impact factor: 3.857

2.  Tay-Sachs disease with altered beta-hexosaminidase B: a new variant?

Authors:  T Momoi; M Sudo; K Tanioka; Y Nakao
Journal:  Pediatr Res       Date:  1978-02       Impact factor: 3.756

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

5.  Biochemical and immunochemical characterization of hexosaminidase P.

Authors:  B Geiger; E Calef; R Arnon
Journal:  Biochemistry       Date:  1978-05-02       Impact factor: 3.162

6.  Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay.

Authors:  J S O'Brien; S Okada; A Chen; D L Fillerup
Journal:  N Engl J Med       Date:  1970-07-02       Impact factor: 91.245

7.  Nonenzymatic conversion of human hexosaminidase A.

Authors:  E Beutler; D Villacorte; W Kuhl; E Guinto; S Srivastava
Journal:  J Lab Clin Med       Date:  1975-08

8.  Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes.

Authors:  F Gilbert; R Kucherlapati; R P Creagan; M J Murnane; G J Darlington; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

9.  Hereditary heat-labile hexosaminidase B: its implication for recognizing Tay-Sachs genotypes.

Authors:  R Navon; J Nutman; R Kopel; L Gaber; N Gadoth; B Goldman; M Nitzan
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

10.  Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A.

Authors:  H Kresse; W Fuchs; J Glössl; D Holtfrerich; W Gilberg
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

View more
  11 in total

1.  Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.

Authors:  E C Landels; I H Ellis; M Bobrow; A H Fensom
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

2.  Hexosaminidase assays.

Authors:  Michaela Wendeler; Konrad Sandhoff
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

3.  Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy.

Authors:  Y Ben-Yoseph; M Potier; D A Mitchell; B A Pack; S B Melançon; H L Nadler
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

4.  Intermediate forms of human beta-N-acetylhexosaminidase lack activity towards 4-methylumbelliferyl beta-N-acetylglucosaminide 6-sulphate.

Authors:  T Beccari; C Emiliani; R Hosseini; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

5.  Fetal hexosaminidase A in mother's serum: pitfalls for carrier detection and prospects for prenatal diagnoses of GM2 gangliosidoses.

Authors:  R Navon; I Lejbkowicz; A Adam
Journal:  Am J Hum Genet       Date:  1987-01       Impact factor: 11.025

6.  Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.

Authors:  Y Ben-Yoseph; D A Mitchell; R M Yager; J T Wei; T H Chen; L Y Shih
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

7.  Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.

Authors:  J Bayleran; P Hechtman; E Kolodny; M Kaback
Journal:  Am J Hum Genet       Date:  1987-10       Impact factor: 11.025

8.  Identification of beta-N-acetylhexosaminidase A in mouse tissues with the fluorigenic substrate 4-methylumbelliferyl-beta-N-acetylglucosamine 6-sulphate.

Authors:  T Beccari; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

Review 9.  Ganglioside biochemistry.

Authors:  Thomas Kolter
Journal:  ISRN Biochem       Date:  2012-12-19

10.  Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening.

Authors:  Jodi D Hoffman; Valerie Greger; Erin T Strovel; Miriam G Blitzer; Mark A Umbarger; Caleb Kennedy; Brian Bishop; Patrick Saunders; Gregory J Porreca; Jaclyn Schienda; Jocelyn Davie; Stephanie Hallam; Charles Towne
Journal:  Mol Genet Genomic Med       Date:  2013-09-16       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.